Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets
1 March 2017
Three EQ-5D value sets (the EQ-5D-3L, crosswalk and EQ-5D-5L) are now available for cost utility analysis in the UK and/or England. The value sets’ characteristics differ,…
Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?
1 February 2017
In 2016 the University of York undertook a review exercise to determine whether NICE’s existing methods and processes are appropriate for assessment of regenerative medicines. The…
Recently Published: MCDA to Elicit Stakeholders’ Preferences: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma
20 December 2016
This paper uses MCDA to obtain preferences on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and then uses these preferences to…
New OHE Research Paper: Uncertainty and Risk in HTA Decision Making
7 December 2016
A new OHE Research Paper has just been published on the topic of uncertainty and risk in health technology assessment (HTA) decision making. The report is…
Eliciting the Relative Value of Life Extension at the End of Life
29 November 2016
Rachel Baker of Glasgow Caledonian University and Koonal Shah of OHE discussed societal viewpoints regarding end of life treatments at a recent seminar.
Presentations and Posters from ISPOR Europe 2016
24 November 2016
ISPOR’s 19th Annual European Congress was held in Vienna, 29 October – 2 November 2016. Several members of the OHE team attended and contributed to the…
Health Economic Evaluation throughout the Ages
15 November 2016
On Wednesday 21st September 2016, Professor Philip Clarke from the University of Melbourne led an OHE Lunchtime Seminar on the topic of: Health Economic Evaluation throughout…
New Publication: Bibliometric Trends of Health Economic Evaluation in Sub-Saharan Africa
8 November 2016
A new study which explores the relationship between sub-Saharan African authors and their respective co-authors has been published in Globalization and Health. The study was a…
OHE at ISPOR Europe 2016: Risk-sharing, Differential Pricing, the Cancer Drugs Fund, and Patient Reported Outcomes
26 October 2016
ISPOR’s 19th Annual European Congress is scheduled for 29 October – 2 November 2016 in Vienna. This post contains a summary of the contributions by various…